Acidic Citrate Dialysis Package with Oxygen Permeation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing dialysis fluids with citric acid have pH levels below 2, which are corrosive and pose handling risks, and also lead to glucose degradation products, causing discoloration and stability issues, necessitating a package that maintains pH above 2 and allows oxygen permeation to minimize these issues.

Innovation Solution

A package containing an acidic citrate concentrate with a citric acid to citrate ratio of 75:25 to 85:15, and a pH of 2 to 3, made of polyolefin materials with an oxygen permeation rate of more than 2 g/m2/24 h at 25° C./90% RH, allowing for the creation of a ready-to-use dialysis fluid with a pH close to physiological levels and reducing glucose degradation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the pH of the dialysis fluid is lowered below 2 to increase citrate solubility and buffering capacity, then the buffering performance is improved, but the fluid becomes corrosive and causes handling risks

Engineering Contradiction:
Improvebuffering performanceVSAvoidcorrosiveness
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the pH parameter from below 2 to above 2, and adjusts the citrate concentration to 28-45 mM to achieve the desired buffering capacity without corrosiveness. This parameter optimization resolves the contradiction between buffering performance and safety.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If the pH of the dialysis fluid is lowered below 2 to enhance acid-base balance control, then the acid-base buffering is improved, but glucose degradation products increase causing discoloration and stability issues

Engineering Contradiction:
Improveacid-base balance controlVSAvoidglucose stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent optimizes the pH to be above 2 and adjusts the citrate concentration to 28-45 mM, which provides sufficient acid-base buffering while minimizing glucose degradation. This parameter optimization resolves the contradiction between buffering control and glucose stability.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution provides a non-corrosive, stable dialysis fluid with reduced glucose degradation and discoloration, maintaining a pH close to physiological levels, thus improving patient safety and treatment efficacy.

Implementation Method 1

The package is made of polyolefin materials with an oxygen permeation rate of more than 2 g/m2/24 h at 25° C./90% RH, allowing for the creation of a ready-to-use dialysis fluid with a pH close to physiological levels and reducing glucose degradation

Methodology Applied
Scientific EffectOxygen permeation: Permeation

Data Source

PatentUS20230181505A1Package for an acidic dialysis fluid concentrate containing citrate and glucose
Publication Date: 2023.06.15 GAMBRO LUNDIA AB
  • US20230181505A1 patent drawing

AI summary

The present invention concerns a package comprising an acidic citrate containing concentrate, an acidic citrate containing concentrate (or acidic citrate containing solution), and a system wherein the acidic citrate containing concentrate is included for providing a dialysis treatment. The acidic citrate containing concentrate contains citric acid and citrate in a molar ratio of 75:25 to 85:15, and has a pH of between 2 and 3.